Trifecta Capital Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History
Trifecta Capital Advisors, LLC
- $478 Billion
- Q3 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 245 shares of XBI stock, worth $24,624. This represents 0.01% of its overall portfolio holdings.
Number of Shares
245
Previous 245
-0.0%
Holding current value
$24,624
Previous $22.7 Million
6.57%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding XBI
# of Institutions
911Shares Held
98.6MCall Options Held
17.9MPut Options Held
31.3M-
Jpmorgan Chase & CO New York, NY12.3MShares$1.23 Billion0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY12MShares$1.2 Billion0.19% of portfolio
-
Bank Of America Corp Charlotte, NC8.98MShares$902 Million0.07% of portfolio
-
Citigroup Inc7.75MShares$779 Million0.45% of portfolio
-
Morgan Stanley New York, NY6.41MShares$645 Million0.05% of portfolio